Triple-negative breast cancer: Correlation between imaging and pathological findings

European Radiology

Volumn 20, Issue 5, 2010, Pages 1111-1117

  Ko, Eun Sook ^a   Lee, Byung Hee ^a   Kim, Hyun A ^a   Noh, Woo Chul ^a   Kim, Min Suk ^a   Lee, Sang Ah ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Breast carcinoma; Breast neoplasm; Mammography; Sonography; Triple negative breast cancer; Ultrasound

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 77952093965     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1656-3     Document Type: Article

References (19)

1. KR Bauer M Brown RD Cress CA Parise V Caggiano 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721 1728 10.1002/cncr.22618 17387718 (Pubitemid 46668532)
2. EA Rakha JS Reis-Filho IO Ellis 2008 Basal-like breast cancer: a critical review J Clin Oncol 26 2568 2581 10.1200/JCO.2007.13.1748 18487574
3. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D 10963602
4. JS Reis-Filho AN Tutt 2008 Triple negative tumors: a critical review Histopathology 52 108 118 10.1111/j.1365-2559.2008.03046.x 1:STN:280: DC%2BD1c%2FgsF2mtg%3D%3D 18171422 (Pubitemid 351724916)
5. MC Cheang D Voduc C Bajdik, et al. 2008 Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368 1376 10.1158/1078-0432.CCR-07-1658 1:CAS:528: DC%2BD1cXislSrs7o%3D 18316557 (Pubitemid 351413917)
6. BG Haffty Q Yang M Reiss, et al. 2006 Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 5652 5657 10.1200/JCO.2006.06.5664 17116942 (Pubitemid 46631305)
7. R Dent M Trudeau KI Pritchard, et al. 2007 Triple-negative cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429 4434 10.1158/1078-0432.CCR-06-3045 17671126 (Pubitemid 47219710)
8. American College of Radiology (2003) Breast imaging reporting and data system (BI-RADS™), 4th edn. American College of Radiology, Reston
9. EA Rakha ME El-Sayed AR Green AH Lee JF Robertson IO Ellis 2007 Prognostic markers in triple-negative breast cancer Cancer 109 25 32 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D 17146782 (Pubitemid 46120191)
10. CA Livasy G Karaca R Nanda, et al. 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 264 271 10.1038/modpathol.3800528 1:CAS:528:DC%2BD28Xlt1eqtw%3D%3D 16341146 (Pubitemid 43117611)
11. LA Carey EC Dees L Sawyer, et al. 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329 2334 10.1158/1078-0432.CCR-06-1109 1:CAS:528:DC%2BD2sXkt1enur0%3D 17438091 (Pubitemid 46698581)
12. S Basu W Chen J Tchou, et al. 2008 Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization Cancer 112 995 1000 10.1002/cncr.23226 1:CAS:528: DC%2BD1cXjs1eqsLo%3D 18098228 (Pubitemid 351304582)
13. T Uematsu M Kasami S Yuen 2009 Triple-negative breast cancer: correlation between MR imaging and pathologic findings Radiology 250 638 647 10.1148/radiol.2503081054 19244039
14. S Schrading CK Kuhl 2008 Mammographic, US, and MR imaging phenotypes of familial breast cancer Radiology 246 58 70 18096529
15. WT Yang GM Tse 2004 Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ AJR Am J Roentgenol 182 101 110 14684521
16. HJ Shin HH Kim SM Kim GY Kwon G Gong OK Cho 2008 Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features AJR Am J Roentgenol 190 516 525 10.2214/AJR.07.2206 18212241 (Pubitemid 351196626)
17. JH Kim ES Ko DY Kim H Han JH Sohn DH Choe 2009 Noncalcified ductal carcinoma in situ: imaging and histologic findings in 36 tumors J Ultrasound Med 28 903 910 19546332
18. WT Yang M Dryden K Broglio, et al. 2008 Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women Breast Cancer Res Treat 111 405 410 10.1007/s10549-007-9810-6 18026834
19. Y Wang DM Ikeda B Narasimhan, et al. 2008 Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression Radiology 246 367 375 10.1148/radiol.2462070169 18180338